Korea’s New Anthrax Vaccine & Health Survey Data Released
Berlin, Germany – In a significant advancement for public health security, South Korea’s GC Pharma, in collaboration with the Korea Disease Control and Prevention Agency (KDCA), has achieved a breakthrough in biodefense with the development of the world’s first recombinant protein anthrax vaccine, ‘Baxltrax.’ The vaccine has been granted marketing authorization by the Ministry of … Read more